Free Trial

Cryoport (CYRX) Financials

Cryoport logo
$5.92 +0.33 (+5.90%)
As of 03:53 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Annual Income Statements for Cryoport

Annual Income Statements for Cryoport

This table shows Cryoport's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
-45 -108 -123
Consolidated Net Income / (Loss)
-37 -100 -115
Net Income / (Loss) Continuing Operations
-37 -100 -115
Total Pre-Tax Income
-35 -99 -113
Total Operating Income
-32 -115 -131
Total Gross Profit
104 99 100
Total Revenue
237 233 228
Total Cost of Revenue
133 134 129
Operating Cost of Revenue
133 134 129
Total Operating Expenses
136 214 230
Selling, General & Admin Expense
120 147 149
Research & Development Expense
16 18 18
Impairment Charge
0.00 50 64
Total Other Income / (Expense), net
-3.19 16 17
Interest Expense
6.14 -0.18 -14
Interest & Investment Income
8.47 11 9.90
Other Income / (Expense), net
-5.52 5.06 -6.91
Income Tax Expense
2.24 0.24 1.28
Preferred Stock Dividends Declared
8.00 8.00 8.00
Basic Earnings per Share
($0.93) ($2.21) ($2.49)
Weighted Average Basic Shares Outstanding
48.99M 48.74M 49.35M
Diluted Earnings per Share
($0.93) ($2.21) ($2.49)
Weighted Average Diluted Shares Outstanding
48.99M 48.74M 49.35M
Weighted Average Basic & Diluted Shares Outstanding
48.34M 48.98M 49.91M

Quarterly Income Statements for Cryoport

This table shows Cryoport's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
-7.32 -11 -7.57 -20 -15 -64 -21 -80 -1.20 -21
Consolidated Net Income / (Loss)
-5.32 -9.44 -5.57 -18 -13 -62 -19 -78 0.81 -19
Net Income / (Loss) Continuing Operations
-5.32 -9.44 -5.57 -18 -13 -62 -19 -78 0.81 -19
Total Pre-Tax Income
-5.26 -7.96 -5.08 -18 -13 -64 -19 -78 1.45 -19
Total Operating Income
-7.80 -11 -10 -18 -17 -70 -21 -79 -16 -14
Total Gross Profit
26 26 27 25 24 23 22 25 25 27
Total Revenue
60 60 63 57 56 57 55 58 57 60
Total Cost of Revenue
34 34 36 32 32 34 33 32 31 32
Operating Cost of Revenue
34 34 36 32 32 34 33 32 31 32
Total Operating Expenses
34 37 37 43 41 93 43 104 42 41
Selling, General & Admin Expense
30 33 33 39 36 39 38 36 38 37
Research & Development Expense
3.99 4.68 3.88 4.26 5.15 4.75 4.75 4.65 4.16 4.16
Total Other Income / (Expense), net
2.54 3.08 4.96 0.61 4.11 6.12 2.60 1.62 18 -4.72
Interest Expense
1.61 1.46 1.51 1.33 -4.32 1.31 1.34 0.07 -16 0.64
Interest & Investment Income
2.49 2.68 2.47 2.65 2.85 2.62 2.60 2.81 3.06 1.43
Other Income / (Expense), net
1.67 1.86 4.01 -0.70 -3.06 4.81 1.34 -1.12 -1.62 -5.51
Income Tax Expense
0.06 1.48 0.49 0.64 0.47 -1.36 0.22 0.38 0.65 0.03
Preferred Stock Dividends Declared
2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00
Basic Earnings per Share
($0.15) ($0.24) ($0.16) ($0.42) ($0.31) ($1.32) ($0.43) ($1.62) ($0.02) ($0.42)
Weighted Average Basic Shares Outstanding
48.52M 48.99M 48.36M 48.71M 48.90M 48.74M 49.02M 49.35M 49.42M 49.35M
Diluted Earnings per Share
($0.15) ($0.24) ($0.16) ($0.42) ($0.31) ($1.32) ($0.43) ($1.62) ($0.02) ($0.42)
Weighted Average Diluted Shares Outstanding
48.52M 48.99M 48.36M 48.71M 48.90M 48.74M 49.02M 49.35M 49.42M 49.35M
Weighted Average Basic & Diluted Shares Outstanding
49.00M 48.34M 45.55M 48.88M 48.96M 48.98M 49.26M 49.41M 49.43M 49.91M

Annual Cash Flow Statements for Cryoport

This table details how cash moves in and out of Cryoport's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Change in Cash & Equivalents
-103 9.75 -1.06
Net Cash From Operating Activities
-1.85 -0.76 -16
Net Cash From Continuing Operating Activities
-1.85 -0.76 -16
Net Income / (Loss) Continuing Operations
-37 -100 -115
Consolidated Net Income / (Loss)
-37 -100 -115
Depreciation Expense
23 27 31
Amortization Expense
2.58 2.53 1.94
Non-Cash Adjustments To Reconcile Net Income
42 71 76
Changes in Operating Assets and Liabilities, net
-32 -2.09 -10
Net Cash From Investing Activities
-60 36 177
Net Cash From Continuing Investing Activities
-60 36 177
Purchase of Property, Plant & Equipment
-24 -44 -20
Acquisitions
-7.17 -8.21 -1.44
Purchase of Investments
-164 -43 -51
Sale and/or Maturity of Investments
132 130 249
Other Investing Activities, net
3.00 0.98 0.00
Net Cash From Financing Activities
-39 -24 -162
Net Cash From Continuing Financing Activities
-39 -24 -162
Repayment of Debt
-3.26 -25 -164
Repurchase of Common Equity
-38 0.00 0.00
Other Financing Activities, net
2.05 1.48 2.79
Effect of Exchange Rate Changes
-1.80 -1.74 -0.02
Cash Interest Paid
3.63 3.40 2.69
Cash Income Taxes Paid
1.98 1.46 1.42

Quarterly Cash Flow Statements for Cryoport

This table details how cash moves in and out of Cryoport's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
-6.31 5.87 1.94 29 -7.84 -13 3.32 -3.21 -1.79 0.62
Net Cash From Operating Activities
0.98 3.65 2.77 -4.05 -1.96 2.48 -3.27 -8.03 0.45 -5.48
Net Cash From Continuing Operating Activities
1.04 3.65 2.77 -4.05 -1.96 2.48 -3.27 -8.03 0.45 -5.48
Net Income / (Loss) Continuing Operations
-5.32 -9.44 -5.57 -18 -13 -62 -19 -78 0.81 -19
Consolidated Net Income / (Loss)
-5.32 -9.44 -5.57 -18 -13 -62 -19 -78 0.81 -19
Depreciation Expense
5.79 6.13 6.40 6.72 6.91 7.45 7.47 7.56 7.84 7.89
Amortization Expense
0.64 0.65 0.64 0.64 0.65 0.60 0.60 0.60 0.42 0.32
Non-Cash Adjustments To Reconcile Net Income
7.55 9.26 3.40 6.35 5.96 55 5.31 70 -7.30 8.30
Changes in Operating Assets and Liabilities, net
-7.62 -2.95 -2.10 0.59 -2.21 1.63 2.25 -8.07 -1.32 -3.32
Net Cash From Investing Activities
-5.87 7.12 -1.38 34 19 -15 6.45 13 154 3.48
Net Cash From Continuing Investing Activities
-5.87 7.12 -1.38 34 19 -15 6.45 13 154 3.48
Purchase of Property, Plant & Equipment
-5.59 -8.37 -10 -11 -11 -12 -4.45 -5.42 -4.93 -5.34
Acquisitions
-4.61 -0.10 -0.18 -0.21 -0.23 -7.60 -0.32 -0.35 -0.46 -0.32
Sale and/or Maturity of Investments
23 24 7.85 45 30 48 25 55 160 9.14
Net Cash From Financing Activities
-0.46 -5.31 0.07 1.15 -25 -0.13 0.51 -8.76 -155 2.01
Net Cash From Continuing Financing Activities
-0.46 -5.31 0.07 1.15 -25 -0.13 0.51 -8.76 -155 2.01
Repayment of Debt
-2.10 -1.15 -0.02 0.01 -25 -0.12 -0.11 -8.77 -155 -0.13
Other Financing Activities, net
1.00 0.45 0.09 1.14 0.25 -0.00 0.62 0.01 0.02 2.14
Effect of Exchange Rate Changes
-0.97 0.40 0.48 -2.00 0.50 -0.72 -0.38 0.26 -0.52 0.61
Cash Interest Paid
0.02 1.72 0.00 1.73 0.07 1.61 0.04 1.57 -0.98 2.06
Cash Income Taxes Paid
0.56 0.70 0.43 0.67 -0.15 0.51 0.42 0.29 0.47 0.24

Annual Balance Sheets for Cryoport

This table presents Cryoport's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Total Assets
1,039 958 703
Total Current Assets
604 535 342
Cash & Equivalents
37 46 45
Short-Term Investments
487 410 216
Accounts Receivable
44 42 46
Inventories, net
28 26 22
Prepaid Expenses
9.32 10 12
Plant, Property, & Equipment, net
64 85 89
Total Noncurrent Assets
371 338 273
Goodwill
151 108 52
Intangible Assets
191 194 170
Noncurrent Deferred & Refundable Income Taxes
0.95 0.66 0.87
Other Noncurrent Operating Assets
28 34 50
Total Liabilities & Shareholders' Equity
1,039 958 703
Total Liabilities
483 469 302
Total Current Liabilities
41 46 65
Short-Term Debt
0.06 0.24 17
Accounts Payable
28 27 27
Current Deferred Revenue
0.44 1.31 1.11
Current Employee Benefit Liabilities
8.46 11 13
Other Current Liabilities
3.85 5.66 5.91
Total Noncurrent Liabilities
442 423 237
Long-Term Debt
407 380 185
Capital Lease Obligations
0.22 0.95 1.25
Noncurrent Deferred & Payable Income Tax Liabilities
4.93 2.82 2.53
Other Noncurrent Operating Liabilities
30 39 48
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
556 489 402
Total Preferred & Common Equity
556 489 402
Preferred Stock
18 26 34
Total Common Equity
538 463 368
Common Stock
1,115 1,131 1,146
Retained Earnings
-543 -642 -757
Accumulated Other Comprehensive Income / (Loss)
-35 -26 -21

Quarterly Balance Sheets for Cryoport

This table presents Cryoport's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
1,034 1,048 1,031 1,001 943 852 702
Total Current Assets
609 605 585 549 526 502 350
Cash & Equivalents
31 39 67 59 50 46 45
Short-Term Investments
499 484 437 406 399 381 228
Accounts Receivable
44 46 43 43 41 40 43
Inventories, net
25 26 29 29 25 24 24
Prepaid Expenses
11 9.96 8.62 12 11 11 11
Plant, Property, & Equipment, net
58 71 69 75 86 87 88
Total Noncurrent Assets
367 372 376 377 331 264 263
Goodwill
147 152 149 149 108 52 54
Intangible Assets
192 188 195 193 190 178 176
Noncurrent Deferred & Refundable Income Taxes
1.64 0.94 0.93 0.86 0.76 1.58 1.67
Other Noncurrent Operating Assets
26 31 31 34 33 31 32
Total Liabilities & Shareholders' Equity
1,034 1,048 1,031 1,001 943 852 702
Total Liabilities
478 488 486 463 471 452 283
Total Current Liabilities
41 42 40 45 49 60 61
Short-Term Debt
1.01 0.06 0.06 0.07 0.11 17 18
Accounts Payable
27 26 26 28 27 25 25
Current Deferred Revenue
0.55 1.01 0.93 1.58 1.78 1.32 1.09
Current Employee Benefit Liabilities
8.63 10 8.72 10 14 11 11
Other Current Liabilities
3.10 4.20 4.43 4.95 5.66 5.66 6.30
Total Noncurrent Liabilities
437 446 446 418 422 392 222
Long-Term Debt
406 408 408 378 380 357 185
Capital Lease Obligations
23 28 0.62 30 29 1.14 1.31
Noncurrent Deferred & Payable Income Tax Liabilities
3.04 5.11 4.66 4.71 2.41 2.65 3.53
Other Noncurrent Operating Liabilities
4.60 5.14 33 4.86 10 32 32
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
556 561 544 538 472 400 419
Total Preferred & Common Equity
556 561 544 538 472 400 419
Preferred Stock
16 20 22 24 28 30 32
Total Common Equity
539 540 522 513 444 370 386
Common Stock
1,086 1,118 1,123 1,127 1,135 1,138 1,141
Retained Earnings
-504 -548 -567 -580 -661 -739 -738
Accumulated Other Comprehensive Income / (Loss)
-43 -30 -34 -34 -30 -29 -16

Annual Metrics and Ratios for Cryoport

This table displays calculated financial ratios and metrics derived from Cryoport's official financial filings.

Metric 2022 2023 2024
Growth Metrics
- - -
Revenue Growth
6.59% -1.70% -2.09%
EBITDA Growth
-1,553.67% -562.98% -31.20%
EBIT Growth
-81.22% -194.18% -25.13%
NOPAT Growth
-78.94% -260.95% -13.64%
Net Income Growth
86.45% -166.75% -15.23%
EPS Growth
84.95% -137.63% -12.67%
Operating Cash Flow Growth
-122.78% 59.10% -2,056.27%
Free Cash Flow Firm Growth
-75.48% -23.25% 59.47%
Invested Capital Growth
5.16% -6.03% -16.86%
Revenue Q/Q Growth
1.68% -1.31% 1.00%
EBITDA Q/Q Growth
11.17% -214.40% 30.35%
EBIT Q/Q Growth
1.41% -103.05% 24.87%
NOPAT Q/Q Growth
-9.14% -104.47% 29.95%
Net Income Q/Q Growth
87.04% -113.55% 27.58%
EPS Q/Q Growth
85.47% -95.58% 26.55%
Operating Cash Flow Q/Q Growth
35.97% -282.41% -95.23%
Free Cash Flow Firm Q/Q Growth
6.15% 13.98% -72,519.87%
Invested Capital Q/Q Growth
-3.73% -13.95% -1.71%
Profitability Metrics
- - -
Gross Margin
43.78% 42.59% 43.62%
EBITDA Margin
-5.09% -34.34% -46.01%
Operating Margin
-13.45% -49.37% -57.30%
EBIT Margin
-15.77% -47.20% -60.32%
Profit (Net Income) Margin
-15.73% -42.69% -50.25%
Tax Burden Percent
106.38% 100.24% 101.12%
Interest Burden Percent
93.77% 90.23% 82.37%
Effective Tax Rate
0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-5.20% -18.90% -24.20%
ROIC Less NNEP Spread (ROIC-NNEP)
3.63% 0.91% 10.38%
Return on Net Nonoperating Assets (RNNOA)
-1.03% -0.17% -1.56%
Return on Equity (ROE)
-6.23% -19.06% -25.76%
Cash Return on Invested Capital (CROIC)
-10.23% -12.68% -5.79%
Operating Return on Assets (OROA)
-3.48% -11.03% -16.59%
Return on Assets (ROA)
-3.47% -9.98% -13.82%
Return on Common Equity (ROCE)
-6.09% -18.25% -24.01%
Return on Equity Simple (ROE_SIMPLE)
-6.72% -20.36% -28.55%
Net Operating Profit after Tax (NOPAT)
-22 -81 -92
NOPAT Margin
-9.41% -34.56% -40.11%
Net Nonoperating Expense Percent (NNEP)
-8.84% -19.80% -34.58%
Return On Investment Capital (ROIC_SIMPLE)
-2.32% -9.26% -15.13%
Cost of Revenue to Revenue
56.22% 57.41% 56.38%
SG&A Expenses to Revenue
50.60% 62.97% 65.23%
R&D to Revenue
6.63% 7.73% 7.75%
Operating Expenses to Revenue
57.22% 91.95% 100.92%
Earnings before Interest and Taxes (EBIT)
-37 -110 -138
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-12 -80 -105
Valuation Ratios
- - -
Price to Book Value (P/BV)
1.58 1.64 1.05
Price to Tangible Book Value (P/TBV)
4.35 4.74 2.64
Price to Revenue (P/Rev)
3.58 3.25 1.68
Price to Earnings (P/E)
0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.71 1.72 1.05
Enterprise Value to Revenue (EV/Rev)
3.17 3.04 1.58
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00
Leverage & Solvency
- - -
Debt to Equity
0.73 0.78 0.51
Long-Term Debt to Equity
0.73 0.78 0.46
Financial Leverage
-0.28 -0.18 -0.15
Leverage Ratio
1.80 1.91 1.86
Compound Leverage Factor
1.68 1.72 1.54
Debt to Total Capital
42.29% 43.80% 33.62%
Short-Term Debt to Total Capital
0.01% 0.03% 2.85%
Long-Term Debt to Total Capital
42.29% 43.77% 30.77%
Preferred Equity to Total Capital
1.90% 3.02% 5.66%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
55.81% 53.18% 60.72%
Debt to EBITDA
-33.72 -4.76 -1.94
Net Debt to EBITDA
9.60 0.94 0.55
Long-Term Debt to EBITDA
-33.72 -4.76 -1.77
Debt to NOPAT
-18.24 -4.73 -2.22
Net Debt to NOPAT
5.19 0.94 0.64
Long-Term Debt to NOPAT
-18.24 -4.72 -2.03
Altman Z-Score
1.09 0.51 -0.59
Noncontrolling Interest Sharing Ratio
2.38% 4.26% 6.80%
Liquidity Ratios
- - -
Current Ratio
14.79 11.73 5.29
Quick Ratio
13.88 10.94 4.76
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
-44 -54 -22
Operating Cash Flow to CapEx
-7.85% -1.72% -81.05%
Free Cash Flow to Firm to Interest Expense
-7.15 0.00 0.00
Operating Cash Flow to Interest Expense
-0.30 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-4.14 0.00 0.00
Efficiency Ratios
- - -
Asset Turnover
0.22 0.23 0.28
Accounts Receivable Turnover
5.70 5.43 5.20
Inventory Turnover
6.04 4.97 5.29
Fixed Asset Turnover
4.21 3.14 2.63
Accounts Payable Turnover
4.71 4.87 4.75
Days Sales Outstanding (DSO)
64.05 67.23 70.20
Days Inventory Outstanding (DIO)
60.44 73.43 68.99
Days Payable Outstanding (DPO)
77.47 75.01 76.83
Cash Conversion Cycle (CCC)
47.01 65.66 62.37
Capital & Investment Metrics
- - -
Invested Capital
440 413 344
Invested Capital Turnover
0.55 0.55 0.60
Increase / (Decrease) in Invested Capital
22 -27 -70
Enterprise Value (EV)
752 709 361
Market Capitalization
850 758 385
Book Value per Share
$10.97 $9.45 $7.44
Tangible Book Value per Share
$3.99 $3.27 $2.94
Total Capital
963 870 605
Total Debt
407 381 204
Total Long-Term Debt
407 381 186
Net Debt
-116 -76 -58
Capital Expenditures (CapEx)
24 44 20
Debt-free, Cash-free Net Working Capital (DFCFNWC)
40 33 33
Debt-free Net Working Capital (DFNWC)
563 490 294
Net Working Capital (NWC)
563 490 277
Net Nonoperating Expense (NNE)
15 19 23
Net Nonoperating Obligations (NNO)
-116 -76 -58
Total Depreciation and Amortization (D&A)
25 30 33
Debt-free, Cash-free Net Working Capital to Revenue
16.88% 14.14% 14.23%
Debt-free Net Working Capital to Revenue
237.44% 209.96% 128.84%
Net Working Capital to Revenue
237.41% 209.86% 121.29%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
($0.93) ($2.21) ($2.49)
Adjusted Weighted Average Basic Shares Outstanding
48.99M 48.74M 49.35M
Adjusted Diluted Earnings per Share
($0.93) ($2.21) ($2.49)
Adjusted Weighted Average Diluted Shares Outstanding
48.99M 48.74M 49.35M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
48.34M 48.98M 49.91M
Normalized Net Operating Profit after Tax (NOPAT)
-22 -46 -47
Normalized NOPAT Margin
-9.41% -19.68% -20.55%
Pre Tax Income Margin
-14.79% -42.59% -49.69%
Debt Service Ratios
- - -
EBIT to Interest Expense
-6.09 0.00 0.00
NOPAT to Interest Expense
-3.64 0.00 0.00
EBIT Less CapEx to Interest Expense
-9.93 0.00 0.00
NOPAT Less CapEx to Interest Expense
-7.48 0.00 0.00
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
-101.68% 0.00% 0.00%

Quarterly Metrics and Ratios for Cryoport

This table displays calculated financial ratios and metrics derived from Cryoport's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
6.65% 6.94% 20.10% -11.12% -7.12% -5.13% -13.09% 1.01% 0.90% 3.97%
EBITDA Growth
26.61% 38.81% 114.72% -270.27% -4,307.46% -2,280.38% -1,281.29% -518.58% 21.19% 80.31%
EBIT Growth
-18.80% 5.53% 52.94% -105.24% -225.48% -608.68% -230.17% -322.09% 9.65% 70.12%
NOPAT Growth
-70.52% -31.95% -28.47% -249.38% -116.70% -533.18% -111.86% -332.18% 23.17% 80.06%
Net Income Growth
18.54% 96.37% 58.42% -100.01% -149.61% -561.18% -238.98% -324.89% 106.07% 70.06%
EPS Growth
16.67% 95.80% 48.39% -82.61% -106.67% -450.00% -168.75% -285.71% 93.55% 68.18%
Operating Cash Flow Growth
-88.94% 39.79% 429.39% 42.18% -299.49% -32.07% -217.70% -97.95% 122.82% -320.79%
Free Cash Flow Firm Growth
92.16% -59.28% -279.07% -174.88% -11.13% 23.51% 152.33% 221.72% 444.47% 367.43%
Invested Capital Growth
6.11% 5.16% 9.84% 5.63% 5.14% -6.03% -8.61% -22.33% -27.21% -16.86%
Revenue Q/Q Growth
-5.75% -0.18% 4.07% -9.23% -1.52% 1.96% -4.66% 5.50% -1.62% 5.06%
EBITDA Q/Q Growth
109.36% -911.86% 141.96% -1,261.29% -6.35% -359.31% 79.18% -508.10% 86.45% -14.77%
EBIT Q/Q Growth
33.85% -49.63% 34.20% -215.17% -4.90% -225.81% 69.35% -302.91% 77.55% -7.74%
NOPAT Q/Q Growth
-48.71% -41.42% 8.97% -82.50% 7.76% -313.22% 69.54% -272.29% 83.60% -7.23%
Net Income Q/Q Growth
42.07% -77.50% 40.93% -229.30% 27.71% -370.19% 69.71% -312.75% 101.03% -2,420.12%
EPS Q/Q Growth
34.78% -60.00% 33.33% -162.50% 26.19% -325.81% 67.42% -276.74% 98.77% -2,000.00%
Operating Cash Flow Q/Q Growth
114.01% 272.10% -24.08% -246.14% 51.68% 226.70% -231.55% -145.79% 105.57% -1,325.95%
Free Cash Flow Firm Q/Q Growth
-137.73% 7.82% -68.93% 25.75% 3.89% 36.55% 215.57% 72.70% 171.98% -50.74%
Invested Capital Q/Q Growth
7.59% -3.73% 7.70% -5.30% 7.08% -13.95% 4.74% -19.52% 0.35% -1.71%
Profitability Metrics
- - - - - - - - - -
Gross Margin
43.69% 43.54% 43.10% 43.38% 43.21% 40.62% 39.89% 43.73% 44.80% 45.83%
EBITDA Margin
0.49% -3.97% 1.60% -20.47% -22.10% -99.56% -21.75% -125.34% -17.26% -18.86%
Operating Margin
-12.91% -18.28% -15.99% -32.15% -30.11% -122.02% -38.98% -137.56% -28.99% -23.40%
EBIT Margin
-10.15% -15.21% -9.62% -33.38% -35.56% -113.62% -36.53% -139.50% -31.84% -32.65%
Profit (Net Income) Margin
-8.79% -15.63% -8.87% -32.19% -23.63% -108.96% -34.61% -135.40% 1.42% -31.37%
Tax Burden Percent
101.08% 118.56% 109.68% 103.58% 103.68% 97.87% 101.15% 100.49% 55.36% 100.16%
Interest Burden Percent
85.72% 86.70% 84.14% 93.09% 64.09% 97.99% 93.67% 96.59% -8.06% 95.93%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 44.64% 0.00%
Return on Invested Capital (ROIC)
-4.75% -7.08% -6.13% -12.40% -10.63% -46.70% -13.55% -54.51% -8.74% -9.88%
ROIC Less NNEP Spread (ROIC-NNEP)
-4.84% -6.07% -7.23% -7.79% -8.79% -32.64% -7.20% -23.93% -24.45% 3.45%
Return on Net Nonoperating Assets (RNNOA)
1.27% 1.72% 1.64% 1.68% 1.25% 5.99% 0.88% 3.73% 3.22% -0.52%
Return on Equity (ROE)
-3.48% -5.36% -4.49% -10.73% -9.38% -40.72% -12.67% -50.78% -5.52% -10.40%
Cash Return on Invested Capital (CROIC)
-10.54% -10.23% -14.66% -13.04% -13.42% -12.68% -10.52% -7.76% -0.01% -5.79%
Operating Return on Assets (OROA)
-2.55% -3.35% -2.24% -7.74% -8.26% -26.55% -8.26% -33.43% -8.46% -8.98%
Return on Assets (ROA)
-2.21% -3.45% -2.07% -7.46% -5.49% -25.46% -7.82% -32.45% 0.38% -8.63%
Return on Common Equity (ROCE)
-3.41% -5.23% -4.37% -10.38% -9.03% -38.98% -12.07% -47.95% -5.19% -9.69%
Return on Equity Simple (ROE_SIMPLE)
-51.82% 0.00% -5.26% -7.11% -8.68% 0.00% -23.91% -43.13% -37.86% 0.00%
Net Operating Profit after Tax (NOPAT)
-5.46 -7.72 -7.03 -13 -12 -49 -15 -55 -9.09 -9.75
NOPAT Margin
-9.03% -12.80% -11.19% -22.50% -21.08% -85.42% -27.29% -96.29% -16.05% -16.38%
Net Nonoperating Expense Percent (NNEP)
0.09% -1.01% 1.10% -4.61% -1.84% -14.07% -6.34% -30.59% 15.71% -13.33%
Return On Investment Capital (ROIC_SIMPLE)
-0.55% -0.80% -0.71% -1.35% -1.25% -5.62% -1.69% -7.15% -1.46% -1.61%
Cost of Revenue to Revenue
56.31% 56.46% 56.90% 56.62% 56.79% 59.38% 60.11% 56.27% 55.20% 54.17%
SG&A Expenses to Revenue
50.01% 54.07% 52.92% 68.05% 64.15% 67.79% 70.16% 62.44% 66.45% 62.25%
R&D to Revenue
6.59% 7.75% 6.17% 7.48% 9.17% 8.29% 8.70% 8.07% 7.34% 6.98%
Operating Expenses to Revenue
56.60% 61.82% 59.09% 75.52% 73.32% 162.65% 78.87% 181.29% 73.79% 69.23%
Earnings before Interest and Taxes (EBIT)
-6.14 -9.18 -6.04 -19 -20 -65 -20 -80 -18 -19
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
0.30 -2.40 1.01 -12 -12 -57 -12 -72 -9.78 -11
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
2.19 1.58 2.15 1.51 1.31 1.64 1.95 0.92 1.04 1.05
Price to Tangible Book Value (P/TBV)
5.91 4.35 5.79 4.42 3.91 4.74 5.93 2.45 2.56 2.64
Price to Revenue (P/Rev)
5.06 3.58 4.68 3.26 2.84 3.25 3.85 1.51 1.77 1.68
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.40 1.71 2.31 1.59 1.33 1.72 1.98 0.92 1.04 1.05
Enterprise Value to Revenue (EV/Rev)
4.71 3.17 4.41 2.96 2.70 3.04 3.80 1.41 1.61 1.58
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 2,740.69 212.24 1,535.58 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.78 0.73 0.78 0.75 0.76 0.78 0.87 0.94 0.49 0.51
Long-Term Debt to Equity
0.77 0.73 0.78 0.75 0.76 0.78 0.87 0.89 0.44 0.46
Financial Leverage
-0.26 -0.28 -0.23 -0.22 -0.14 -0.18 -0.12 -0.16 -0.13 -0.15
Leverage Ratio
1.54 1.80 1.82 1.87 1.86 1.91 1.93 1.99 1.78 1.86
Compound Leverage Factor
1.32 1.56 1.53 1.74 1.19 1.87 1.81 1.93 -0.14 1.79
Debt to Total Capital
43.66% 42.29% 43.74% 42.91% 43.19% 43.80% 46.43% 48.41% 32.74% 33.62%
Short-Term Debt to Total Capital
0.10% 0.01% 0.01% 0.01% 0.01% 0.03% 0.01% 2.24% 2.82% 2.85%
Long-Term Debt to Total Capital
43.56% 42.29% 43.74% 42.90% 43.19% 43.77% 46.42% 46.17% 29.92% 30.77%
Preferred Equity to Total Capital
1.65% 1.90% 2.04% 2.34% 2.57% 3.02% 3.21% 3.90% 5.19% 5.66%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
54.69% 55.81% 54.22% 54.76% 54.24% 53.18% 50.36% 47.68% 62.07% 60.72%
Debt to EBITDA
-31.67 -33.72 -102.62 -32.04 -16.05 -4.76 -4.40 -2.45 -1.35 -1.94
Net Debt to EBITDA
7.27 9.60 20.44 7.49 2.24 0.94 0.42 0.34 0.46 0.55
Long-Term Debt to EBITDA
-31.60 -33.72 -102.60 -32.04 -16.04 -4.76 -4.40 -2.33 -1.23 -1.77
Debt to NOPAT
-21.05 -18.24 -18.24 -12.38 -10.37 -4.73 -4.63 -2.86 -1.56 -2.22
Net Debt to NOPAT
4.83 5.19 3.63 2.89 1.45 0.94 0.44 0.39 0.53 0.64
Long-Term Debt to NOPAT
-21.00 -18.24 -18.24 -12.37 -10.37 -4.72 -4.62 -2.73 -1.42 -2.03
Altman Z-Score
1.67 1.17 1.56 1.01 0.83 0.66 0.90 -0.19 0.11 -0.04
Noncontrolling Interest Sharing Ratio
2.04% 2.38% 2.78% 3.28% 3.71% 4.26% 4.70% 5.56% 5.91% 6.80%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
14.96 14.79 14.54 14.54 12.23 11.73 10.73 8.38 5.70 5.29
Quick Ratio
14.09 13.88 13.66 13.61 11.32 10.94 10.00 7.80 5.15 4.76
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-32 -29 -49 -37 -35 -22 26 45 122 60
Operating Cash Flow to CapEx
17.56% 43.67% 27.65% -37.73% -17.39% 20.71% -73.39% -148.04% 9.07% -102.54%
Free Cash Flow to Firm to Interest Expense
-19.75 -20.12 -32.79 -27.61 0.00 -17.16 19.35 677.63 0.00 94.22
Operating Cash Flow to Interest Expense
0.61 2.51 1.84 -3.05 0.00 1.90 -2.44 -121.59 0.00 -8.62
Operating Cash Flow Less CapEx to Interest Expense
-2.86 -3.24 -4.81 -11.12 0.00 -7.28 -5.77 -203.73 0.00 -17.02
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.25 0.22 0.23 0.23 0.23 0.23 0.23 0.24 0.27 0.28
Accounts Receivable Turnover
5.63 5.70 6.09 5.53 5.43 5.43 5.18 5.42 5.25 5.20
Inventory Turnover
6.98 6.04 5.73 5.25 5.00 4.97 5.09 5.00 4.96 5.29
Fixed Asset Turnover
4.64 4.21 4.06 3.91 3.58 3.14 2.86 2.90 2.78 2.63
Accounts Payable Turnover
4.68 4.71 5.14 4.76 4.85 4.87 4.92 5.15 4.92 4.75
Days Sales Outstanding (DSO)
64.82 64.05 59.96 65.96 67.21 67.23 70.42 67.33 69.48 70.20
Days Inventory Outstanding (DIO)
52.32 60.44 63.66 69.55 73.06 73.43 71.76 72.98 73.64 68.99
Days Payable Outstanding (DPO)
77.97 77.47 71.03 76.68 75.33 75.01 74.17 70.89 74.21 76.83
Cash Conversion Cycle (CCC)
39.16 47.01 52.59 58.83 64.94 65.66 68.01 69.42 68.90 62.37
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
457 440 474 449 480 413 433 348 350 344
Invested Capital Turnover
0.53 0.55 0.55 0.55 0.50 0.55 0.50 0.57 0.54 0.60
Increase / (Decrease) in Invested Capital
26 22 42 24 23 -27 -41 -100 -131 -70
Enterprise Value (EV)
1,099 752 1,094 712 637 709 856 319 364 361
Market Capitalization
1,181 850 1,160 786 670 758 867 340 401 385
Book Value per Share
$11.12 $10.97 $11.18 $11.46 $10.50 $9.45 $9.06 $7.51 $7.82 $7.44
Tangible Book Value per Share
$4.12 $3.99 $4.15 $3.90 $3.51 $3.27 $2.99 $2.82 $3.17 $2.94
Total Capital
986 963 996 953 946 870 881 776 622 605
Total Debt
431 407 436 409 409 381 409 375 204 204
Total Long-Term Debt
430 407 436 409 409 381 409 358 186 186
Net Debt
-99 -116 -87 -96 -57 -76 -39 -52 -69 -58
Capital Expenditures (CapEx)
5.59 8.37 10 11 11 12 4.45 5.42 4.93 5.34
Debt-free, Cash-free Net Working Capital (DFCFNWC)
40 40 40 40 38 33 28 32 34 33
Debt-free Net Working Capital (DFNWC)
569 563 563 545 504 490 477 460 306 294
Net Working Capital (NWC)
568 563 563 545 504 490 477 442 289 277
Net Nonoperating Expense (NNE)
-0.15 1.71 -1.46 5.52 1.43 13 4.00 23 -9.90 8.93
Net Nonoperating Obligations (NNO)
-99 -116 -87 -96 -57 -76 -39 -52 -69 -58
Total Depreciation and Amortization (D&A)
6.43 6.79 7.05 7.37 7.56 8.05 8.07 8.16 8.26 8.21
Debt-free, Cash-free Net Working Capital to Revenue
17.09% 16.88% 16.34% 16.75% 16.27% 14.14% 12.57% 14.35% 14.95% 14.23%
Debt-free Net Working Capital to Revenue
244.00% 237.44% 227.25% 226.46% 213.37% 209.96% 211.90% 203.68% 135.54% 128.84%
Net Working Capital to Revenue
243.57% 237.41% 227.23% 226.43% 213.34% 209.86% 211.85% 195.96% 127.77% 121.29%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($0.15) ($0.24) ($0.16) ($0.42) ($0.31) ($1.32) ($0.43) ($1.62) ($0.02) ($0.42)
Adjusted Weighted Average Basic Shares Outstanding
48.52M 48.99M 48.36M 48.71M 48.90M 48.74M 49.02M 49.35M 49.42M 49.35M
Adjusted Diluted Earnings per Share
($0.15) ($0.24) ($0.16) ($0.42) ($0.31) ($1.32) ($0.43) ($1.62) ($0.02) ($0.42)
Adjusted Weighted Average Diluted Shares Outstanding
48.52M 48.99M 48.36M 48.71M 48.90M 48.74M 49.02M 49.35M 49.42M 49.35M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
49.00M 48.34M 45.55M 48.88M 48.96M 48.98M 49.26M 49.41M 49.43M 49.91M
Normalized Net Operating Profit after Tax (NOPAT)
-5.46 -7.72 -7.03 -13 -12 -14 -15 -11 -9.09 -9.75
Normalized NOPAT Margin
-9.03% -12.80% -11.19% -22.50% -21.08% -24.82% -27.29% -18.74% -16.05% -16.38%
Pre Tax Income Margin
-8.70% -13.19% -8.09% -31.08% -22.79% -111.33% -34.22% -134.74% 2.57% -31.32%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
-3.81 -6.30 -4.00 -14.30 0.00 -49.81 -14.90 -1,217.41 0.00 -30.56
NOPAT to Interest Expense
-3.39 -5.31 -4.66 -9.64 0.00 -37.45 -11.13 -840.30 0.00 -15.33
EBIT Less CapEx to Interest Expense
-7.29 -12.05 -10.65 -22.37 0.00 -58.99 -18.23 -1,299.55 0.00 -38.97
NOPAT Less CapEx to Interest Expense
-6.87 -11.05 -11.31 -17.71 0.00 -46.63 -14.46 -922.43 0.00 -23.74
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-11.58% -101.68% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Cryoport's Financials

When does Cryoport's fiscal year end?

According to the most recent income statement we have on file, Cryoport's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Cryoport's net income changed over the last 2 years?

Cryoport's net income appears to be on an upward trend, with a most recent value of -$114.76 million in 2024, rising from -$37.33 million in 2022. The previous period was -$99.59 million in 2023.

What is Cryoport's operating income?
Cryoport's total operating income in 2024 was -$130.87 million, based on the following breakdown:
  • Total Gross Profit: $99.63 million
  • Total Operating Expenses: $230.50 million
How has Cryoport revenue changed over the last 2 years?

Over the last 2 years, Cryoport's total revenue changed from $237.28 million in 2022 to $228.39 million in 2024, a change of -3.7%.

How much debt does Cryoport have?

Cryoport's total liabilities were at $301.59 million at the end of 2024, a 35.7% decrease from 2023, and a 37.5% decrease since 2022.

How much cash does Cryoport have?

In the past 2 years, Cryoport's cash and equivalents has ranged from $36.60 million in 2022 to $46.35 million in 2023, and is currently $45.29 million as of their latest financial filing in 2024.

How has Cryoport's book value per share changed over the last 2 years?

Over the last 2 years, Cryoport's book value per share changed from 10.97 in 2022 to 7.44 in 2024, a change of -32.2%.



This page (NASDAQ:CYRX) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners